ABCG2 is overexpressed on red blood cells in Ph-negative myeloproliferative neoplasms and potentiates ruxolitinib-induced apoptosis
| dc.contributor.author | Buks, Ralfs | |
| dc.contributor.author | Brusson, Mégane | |
| dc.contributor.author | Cochet, Sylvie | |
| dc.contributor.author | Galochkina, Tatiana | |
| dc.contributor.author | Cassinat, Bruno | |
| dc.contributor.author | Nemazanyy, Ivan | |
| dc.contributor.author | Peyrard, Thierry | |
| dc.contributor.author | Kiladjian, Jean Jacques | |
| dc.contributor.author | de Brevern, Alexandre G. | |
| dc.contributor.author | Azouzi, Slim | |
| dc.contributor.author | Nemer, Wassim El | |
| dc.contributor.institution | University of Aberdeen.Biological Sciences | en |
| dc.date.accessioned | 2021-12-27T19:49:01Z | |
| dc.date.available | 2021-12-27T19:49:01Z | |
| dc.date.issued | 2021-04-01 | |
| dc.description | Acknowledgments: The authors would like to thank Dominique Gien, Sirandou Tounkara, and Eliane Véra at Centre National de Référence pour les Groupes Sanguins for the management of blood samples. Funding: The work was supported by Institut National de la Santé et de la Recherche Médicale (Inserm), Institut National de la Transfusion Sanguine (INTS), the University of Paris, and grants from Laboratory of Excellence (Labex) GR-Ex, reference No. ANR-11-LABX-0051. The Labex GR-Ex is funded by the IdEx program “Investissements d’avenir” of the French National Research Agency, reference No. ANR-18-IDEX-0001. R.B. was funded by the European Union’s Horizon 2020 Research and Innovation Program under grant agreement No. 675115-RELEVANCE-H2020-MSCA-ITN-2015. M.B. was funded by Ministère de l’Enseignement Supérieur et de la Recherche at the BioSPC Doctoral School. R.B. and M.B. also received financial support from Société Française d’Hématologie (SFH) and Club du Globule Rouge et du Fer (CGRF). | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 18 | |
| dc.format.extent | 6374054 | |
| dc.identifier | 210723335 | |
| dc.identifier | baf57215-25f0-42c9-845e-601b40247d72 | |
| dc.identifier | 85103103255 | |
| dc.identifier | 33805426 | |
| dc.identifier.citation | Buks, R, Brusson, M, Cochet, S, Galochkina, T, Cassinat, B, Nemazanyy, I, Peyrard, T, Kiladjian, J J, de Brevern, A G, Azouzi, S & Nemer, W E 2021, 'ABCG2 is overexpressed on red blood cells in Ph-negative myeloproliferative neoplasms and potentiates ruxolitinib-induced apoptosis', International Journal of Molecular Sciences, vol. 22, no. 7, 3530. https://doi.org/10.3390/ijms22073530 | en |
| dc.identifier.doi | 10.3390/ijms22073530 | |
| dc.identifier.other | ORCID: /0000-0002-0282-4500/work/91418120 | |
| dc.identifier.uri | https://hdl.handle.net/2164/17776 | |
| dc.identifier.url | https://www.scopus.com/pages/publications/85103103255 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | International Journal of Molecular Sciences | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | polycythemia vera | en |
| dc.subject | JAK2V617F | en |
| dc.subject | red blood cells | en |
| dc.subject | ABCG2 | en |
| dc.subject | ruxolitinib | en |
| dc.subject | hydroxyurea | en |
| dc.subject | Ruxolitinib | en |
| dc.subject | Red blood cells | en |
| dc.subject | Hydroxyurea | en |
| dc.subject | Polycythemia vera | en |
| dc.subject | QH301 Biology | en |
| dc.subject | Molecular Biology | en |
| dc.subject | Spectroscopy | en |
| dc.subject | Catalysis | en |
| dc.subject | Inorganic Chemistry | en |
| dc.subject | Computer Science Applications | en |
| dc.subject | Physical and Theoretical Chemistry | en |
| dc.subject | Organic Chemistry | en |
| dc.subject | European Commission | en |
| dc.subject | 675115-RELEVANCE-H2020-MSCA-ITN-2015 | en |
| dc.subject.lcc | QH301 | en |
| dc.title | ABCG2 is overexpressed on red blood cells in Ph-negative myeloproliferative neoplasms and potentiates ruxolitinib-induced apoptosis | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Buks_etal_ABCG2_Is_Overexpressed_VOR.pdf
- Size:
- 6.08 MB
- Format:
- Adobe Portable Document Format
